分子显影剂的全球市场(～2028年)

本报告提供全球分子显影剂市场调查，市场概要，市场趋势，及企业简介等整体性资讯。

目录

• 摘要整理
• 进化的影像诊断市场
• 显影剂产品市场区隔
• 抗体
• 共轭放射性同位素
• 代谢生物标记
• 光探针
• 奈米粒子
• 标的显影剂
• 活性化可能型显影剂
• 显影剂市场区隔的演进
• 疾病检测
• 影像诱导药物输送
• 生理学流程的製图
• 治疗筛检
• 治疗评估
• 鑑别诊断
• 分子显影剂和显像模式
• MRI
• 光学成像
• PET
• SPECT
• 超音波
• 药物类别
• Affibodies
• 抗体片段
• 免疫因素为目标的抗体
• 单株抗体
• 嵌合体单株抗体
• 奈米粒子
• 临床应用
• 细胞凋亡
• 心臟病
• 血管新生
• 腺苷受体
• 血管内皮层生长因子受体
• 免疫学
• 自体免疫和发炎
• 代谢
• 糖尿病
• 神经学
• 淀粉样肽
• 末梢苯二氮平类受体
• 多巴胺受体
• 代谢型麸胺酸
• 正肾上腺素转运体
• P-糖蛋白质转运体
• 血清素受体
• 血清素转运体
• 大麻素受体
• 肿瘤学
• 雌激素受体
• 葡萄糖转运体
• L型氨基酸转运体
• 基质金属蛋白酶
• 黑皮质素-1
• 前列腺特异性薄膜抗原(PSMA)
• 总和受体
• 生长抑制素受体
• 市场要素
• 指导，规则，规定
• FDA
• 企业简介

Imaging agents that function at the Molecular and Cellular Level

The ability of molecular imaging agents to improve diagnostic and treatment capabilities is now driving a directed effort to develop new agents with enhanced specificity. To sense biological processes such as gene expression, angiogenesis, apoptosis or cell trafficking in vivo, imaging reporter agents that interact specifically with molecular targets and appropriate imaging systems are currently under development. Molecular imaging will greatly reduce the need for animal tissue sampling or human biopsy when studying the progression of a disease or the follow-up of a gene therapy. It has the advantage of being non-invasive, and because it can be repeated many times, it provides both spatial and temporal dimensions to the understanding of the gene expression of the disease or therapy.

What You Will Learn:

• Analyzes molecular imaging agents by category, target and method of detection, and assesses their capabilities, benefits, limitations and potential

• Examines evolving imaging market segments and their impact on the diagnostic imaging sector

• Analyzes key industry alliances and partnerships by imaging modality, and examines the impact of next-generation imaging candidates on future imaging markets

• Profiles market participants, their development activity and business strategies

• Evaluates the impact of economic, technology, and regulatory factors on the development and commercialization of emerging imaging agents

Table of Contents

• Executive Summary
• The Evolving Diagnostic Imaging Market
• Imaging Agent Product Segments
• Antibodies
• Conjugated Radioisotopes
• Metabolic Biomarkers
• Optical Probes
• Nanoparticles
• Targeted Imaging Agents
• Activatable Imaging Agents
• Evolution in Imaging Agent Market Segments
• Disease Detection
• Image-Guided Drug Delivery
• Physiological Process Mapping
• Therapeutic Screening
• Treatment Assessment
• Differential Diagnosis
• Molecular Imaging Agents & Imaging Modalities
• MRI
• Optical Imaging
• PET
• SPECT
• Ultrasound
• Agent Categories
• Affibodies
• Antibody Fragments
• Antibodies Targeting Immune Factors
• mAbs
• Chimeric mAbs
• Nanoparticles
• Clinical Applications
• Apoptosis
• Cardiology
• Angiogenesis
• Adenosine Receptors
• Vascular Endothelial Growth Factor Receptors
• Immunology
• Autoimmunity & Inflammation
• Metabolic
• Diabetes
• Neurology
• Amyloid Peptides
• Peripheral Benzodiazepine Receptors
• Dopamine Receptors
• Metabotropic Glutamate
• Norepinephrine Transporter
• P-glycoprotein Transporter
• Serotonin Receptors
• Serotonin Transporter
• Cannabinoid Receptors
• Oncology
• Estrogen Receptor
• Glucose Transporters
• L-Type Amino Acid Transporter
• Matrix Metalloproteinase
• Melanocortin-1
• Prostate-specific Membrane Antigen (PSMA)
• Sigma Receptors
• Somatostatin Receptors
• Market Factors
• Guidance, Rules and Regulations
• FDA
• Company Profiles